Abstract |
Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells. It is conceivable, therefore, to hypothesize that the cytostatic effect induced by this agent is at least partially associated with a molecular mechanism that involves histone deacetylase 1 (HDAC1) inhibition, as demonstrated for sodium butyrate and other specific inhibitors, such as trichostatin A and hydroxamic acids. Here, we show that, after administration, 9-HSA causes an accumulation of hyperacetylated histones and strongly inhibits the activity of HDAC1. The interaction of 9-HSA with the catalytic site of the enzyme has been highlighted by computational modeling of the human HDAC1, using its homolog from the hyperthermophilic Aquifex aeolicus as a template. Consistent with the experimental data, we find that 9-HSA can bind to the active site of the protein, showing that the inhibition of the enzyme can be explained at the molecular level by the ligand- protein interaction.
|
Authors | Natalia Calonghi, Concettina Cappadone, Eleonora Pagnotta, Carla Boga, Carlo Bertucci, Jessica Fiori, Gianluca Tasco, Rita Casadio, Lanfranco Masotti |
Journal | Journal of lipid research
(J Lipid Res)
Vol. 46
Issue 8
Pg. 1596-603
(Aug 2005)
ISSN: 0022-2275 [Print] United States |
PMID | 15716589
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Histone Deacetylase Inhibitors
- Histones
- Ligands
- Stearic Acids
- 9-hydroxystearic acid
- HDAC1 protein, human
- Histone Deacetylase 1
|
Topics |
- Acetylation
- Catalytic Domain
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Colonic Neoplasms
(drug therapy, pathology)
- Histone Deacetylase 1
- Histone Deacetylase Inhibitors
- Histones
(metabolism)
- Humans
- Ligands
- Models, Molecular
- Protein Binding
- Stearic Acids
(pharmacology)
|